Fingerprint Dive into the research topics of 'Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer
Julie Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried E.E. Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E. Vokes, Esther Holgado, David Waterhouse, Neal Ready, Justin Gainor, Osvaldo Arén Frontera, Libor Havel, Martin Steins, Marina C. Garassino, Joachim G. Aerts, Manuel Domine, Luis Paz-Ares
Research output: Contribution to journal › Article › peer-review